Washington State University published a study in November of 2019 with the summary results showing inhaled cannabis reduced self-reported headache severity by nearly 47.3% and migraine severity by 49.6%.
This study was conducted by researchers working for Dana Farber Cancer Institute and Harvard Medical School. Animal models were used to assess impact of FBL-03G – a flavonoid derived from Cannabis sativa - on the progression of tumors. Therapeutic efficacy in both local and metastatic tumor progression was shown with pancreatic cancer.
Fibromyalgia patients may be heading to medical cannabis dispensaries due to new scientific studies. A 2019 study in the Journal Pain reports pharmaceutical grade cannabis may have some real pain relieving effects on fibromyalgia sufferers. An earlier study by the National Pain Foundation concluded cannabis to be more effective than the top 3 FDA approved drugs.